ReviewInflammopharmacology2012

New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Michael Maes et al.PubMed ↗Publisher ↗

No numbers read from the abstract.